PERSPECTIVES FROM MASTERS IN RHEUMATOLOGY AND AUTOIMMUNITY: Can We Get Closer to a Cure for Rheumatoid Arthritis?

被引：44

作者：

Feldmann, Marc ^{[1
,2
]}

Maini, Ravinder N. ^{[1
,2
]}

机构：

[1] Kennedy Inst Rheumatol, Oxford, England

[2] Univ Oxford, Oxford OX3 7LD, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷 / 09期

关键词：

TUMOR-NECROSIS-FACTOR; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; PERSONALIZED MEDICINE; DISEASE-ACTIVITY; FACTOR-ALPHA; PHASE-II; BLOCKADE; EFFICACY; METHOTREXATE;

D O I：

10.1002/art.39269

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Welcome to our new series, Perspectives From Masters in Rheumatology and Autoimmunity. Our goal in publishing this series of articles is to give readers the opportunity to hear the rich perspectives of individuals in rheumatology who have contributed mightily-indeed have led their fields-in a specific rheumatic disease or in a specific discipline related to the study of autoimmunity. Dr. Paul Plotz' article on autoimmunity in the November 2014 issue, which was transcribed from one of his inspiring lectures, sparked this idea. Authors have been given relatively free rein to develop their ideas that have had and will have the most impact on the field, without encumbering them with bibliography requirements. We are thrilled that our inaugural Perspectives article is written by Professors Sir Marc Feldmann and Sir Ravinder Maini, winners of the Lasker and many other awards for their groundbreaking work in establishing the role of tumor necrosis factor in the pathogenesis of rheumatoid arthritis and in the development of tumor necrosis factor antagonists which have transformed the lives of our patients with rheumatoid arthritis. Enjoy, and stay tuned for the next Perspectives article, by Professor James Fries.

引用

页码：2283 / 2291

页数：9

共 61 条

[1] Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis [J].

Afuwape, AO ;

Feldmann, M ;

Paleolog, EM .

GENE THERAPY, 2003, 10 (23) :1950-1960

[2] Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction [J].

Aletaha, Daniel ;

Funovits, Julia ;

Smolen, Josef S. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) :733-739

[3] Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway [J].

Alzabin, Saba ;

Abraham, Sonya M. ;

Taher, Taher E. ;

Palfreeman, Andrew ;

Hull, Dobrina ;

McNamee, Kay ;

Jawad, Ali ;

Pathan, Ejaz ;

Kinderlerer, Anne ;

Taylor, Peter C. ;

Williams, Richard ;

Mageed, Rizgar .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (10) :1741-1748

[4] High prevalence of autoantibodies among Danish centenarians [J].

Andersen-Ranberg, K ;

Hoier-Madsen, M ;

Wiik, A ;

Jeune, B ;

Hegedüs, L .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01) :158-163

[5] Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum [J].

Bendall, Sean C. ;

Simonds, Erin F. ;

Qiu, Peng ;

Amir, El-ad D. ;

Krutzik, Peter O. ;

Finck, Rachel ;

Bruggner, Robert V. ;

Melamed, Rachel ;

Trejo, Angelica ;

Ornatsky, Olga I. ;

Balderas, Robert S. ;

Plevritis, Sylvia K. ;

Sachs, Karen ;

Pe'er, Dana ;

Tanner, Scott D. ;

Nolan, Garry P. .

SCIENCE, 2011, 332 (6030) :687-696

[6] Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients [J].

Benham, Helen ;

Nel, Hendrik J. ;

Law, Soi Cheng ;

Mehdi, Ahmed M. ;

Street, Shayna ;

Ramnoruth, Nishta ;

Pahau, Helen ;

Lee, Bernett T. ;

Ng, Jennifer ;

Brunck, Marion E. G. ;

Hyde, Claire ;

Trouw, Leendert A. ;

Dudek, Nadine L. ;

Purcell, Anthony W. ;

O'Sullivan, Brendan J. ;

Connolly, John E. ;

Paul, Sanjoy K. ;

Le Cao, Kim-Anh ;

Thomas, Ranjeny .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (290)

[7] Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis [J].

Boers, M ;

Verhoeven, AC ;

Markusse, HM ;

vandeLaar, MAFJ ;

Westhovens, R ;

vanDenderen, JC ;

vanZeben, D ;

Dijkmans, BAC ;

Peeters, AJ ;

Jacobs, P ;

vandenBrink, HR ;

Schouten, HJA ;

vanderHeijde, DMFM ;

Boonen, A ;

vanderLinden, S .

LANCET, 1997, 350 (9074) :309-318

[8] The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis [J].

Boyle, D. L. ;

Soma, K. ;

Hodge, J. ;

Kavanaugh, A. ;

Mandel, D. ;

Mease, P. ;

Shurmur, R. ;

Singhal, A. K. ;

Wei, N. ;

Rosengren, S. ;

Kaplan, I. ;

Krishnaswami, S. ;

Luo, Z. ;

Bradley, J. ;

Firestein, G. S. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :1311-1316

[9] INNOVATION Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications [J].

Brown, Brian D. ;

Naldini, Luigi .

NATURE REVIEWS GENETICS, 2009, 10 (08) :578-585

[10] THE EFFICACY AND SAFETY OF LOW-DOSE CORTICOSTEROIDS FOR RHEUMATOID-ARTHRITIS [J].

CALDWELL, JR ;

FURST, DE .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 21 (01) :1-11

← 1 2 3 4 5 6 7 →